Moderna is pricing coronavirus vaccine at $32 to $37 per dose for some customers
Moderna is charging between $32 to $37 per dose for its coronavirus vaccine for some customers, under cheaper "pandemic pricing," the company said Wednesday.
The Cambridge, Massachusetts-based company is currently in discussion for larger volume agreements that will have a lower price, Moderna CEO Stephane Bancel said on a conference call discussing the company's second-quarter financial results.
"We are working with governments around the world and others to ensure a vaccine is accessible regardless of ability to pay," he said. "We're currently in a pandemic as defined by WHO. At Moderna, like many experts, we believe the virus is not going away and there will be a need to vaccinate people or give them a boost for many years to come."
Moderna defines a small order of its vaccine as "in the millions," he said. The price Moderna is charging for small orders is higher than the $19.50 per dose agreed to by U.S. drugmaker Pfizer and German biotech BioNTech in a deal with the U.S. government.
Bancel said the vaccine will be priced "well-below value" during the pandemic period. After the virus is under control and considered endemic, the pricing will follow traditional market pricing in line with other commercial vaccines, he said.
"We'll work with the market," Bancel said.
The comments came after the company reported a fivefold increase in second-quarter revenue.
Moderna said it has begun talks with multiple countries to supply its potential coronavirus vaccine, called mRNA-1273, and has already received about $400 million in ...
More on: www.cnbc.com